Tag Archives: FDA

Rexulti Fails to Get Results

Posted on November 26, 2018 by cchrstl

REXULTI (generic brexpiprazole) is a prescription psychiatric drug from Otsuka Pharmaceutical Company and Lundbeck pharmaceutical company. Although it failed Phase II clinical trials for attention-deficit hyperactivity disorder (ADHD), it was approved by the U.S. Food and Drug Administration (FDA) in … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Comments Off on Rexulti Fails to Get Results

You May Be Seeing Things That Aren’t Really There

Posted on August 27, 2018 by cchrstl

But You Can See The Wool Being Pulled Over Your Eyes Hallucinations and delusions are possible complications of Parkinson’s disease (PD). They are often referred to as PD psychosis. It’s estimated to occur in up to 50 percent of people … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Comments Off on You May Be Seeing Things That Aren’t Really There

Smoking is So Last Year

Posted on February 15, 2018 by cchrstl

“Given the disproportionate burden of tobacco health harms in psychiatric patients, e-cigarettes are being considered as a potential tool for harm reduction.” E-cigs are battery-powered devices that typically contain nicotine, flavorings, and other chemicals. The liquid is heated into an … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on Smoking is So Last Year

Psychiatric Drugs Putting Veterans at Risk of Dementia

Posted on November 20, 2017 by cchrstl

Almost a third of drugs cleared by the Food and Drug Administration pose safety risks that are identified only after their approval. A research study published in January, 2017 set out to determine the impact of psychotropic medication use on the association between … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Comments Off on Psychiatric Drugs Putting Veterans at Risk of Dementia

What is Happiness?

Posted on November 6, 2017 by cchrstl

If you want happiness for an hour — take a nap. If you want happiness for a day — go fishing. If you want happiness for a year — inherit a fortune. If you want happiness for a lifetime — … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , | Comments Off on What is Happiness?

Las Vegas in the Sights

Posted on October 5, 2017 by cchrstl

Stephen Paddock massacred country music fans at an outdoor concert in Las Vegas the night of October 1, 2017 leaving 59 people dead (including Paddock) and 527 injured at last count. He was prescribed an anti-anxiety drug in June that … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on Las Vegas in the Sights

Psychiatry Ecstatic About PTSD

Posted on September 5, 2017 by cchrstl

The FDA just approved MDMA as a “breakthrough” drug for so-called PTSD and given the OK for clinical trials. The FDA says that the “Breakthrough Therapy” designation expedites the development of drugs intended to treat a serious condition where preliminary … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Comments Off on Psychiatry Ecstatic About PTSD

Bronx Cop Killer Alexander Bonds Was Taking Psych Drugs

Posted on July 6, 2017 by cchrstl

According to the New York Daily News, Alexander Bonds who killed Officer Miosotis Familia as she sat inside a parked police vehicle on July 5, was likely taking psychiatric drugs known to cause violence and suicide. Bonds was shot to … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , | Comments Off on Bronx Cop Killer Alexander Bonds Was Taking Psych Drugs

Contrave Contrived to Confuse

Posted on April 24, 2017 by cchrstl

Contrave is marketed as a prescription weight-loss drug made from a combination of naltrexone HCL and bupropion HCL. Bupropion is an antidepressant, also marketed as Wellbutrin and Zyban for smoking cessation. Naltrexone is used to counteract alcohol and opioid addiction. … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on Contrave Contrived to Confuse

The FDA’s bow to barbarism

Posted on March 30, 2017 by cchrstl

Downgrading the brain injury risks from shock therapy is unjustified Attorney Jonathan W. Emord’s opinion piece in The Washington Times (10/12/2016) says it all — the US Food and Drug Administration wants to re-classify electroconvulsive therapy (ECT) machines so that … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on The FDA’s bow to barbarism